Massachusetts, Cambridge Saturday, March 1, 2025, 18:00 Hrs [IST] ...

Culver City, California Saturday, March 1, 2025, 17:00 Hrs [IST] ...

US FDA approves first human milk-based fortifier for infants to support growth and recovery following surgery for gastroschisis: Duarte, California Saturday, March 1, 2025, 16:00 ...

MYndspan & MEGIN partner to make magnetoencephalography brain scans more accessible: London Saturday, March 1, 2025, 15:00 Hrs [IST] MYndspan, a pioneer in consumer brain health t ...

Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma: Hefei, China Saturday, March 1, 2025, 14:00 Hrs [IST] Kangpu Bioph ...

Akeso begins patient enrolment in phase I trial of AK138 D1 for the treatment of advanced malignancies in Australia: Hong Kong Saturday, March 1, 2025, 12:00 Hrs [IST] Akeso, Inc.

Planegg, Martinsried Saturday, March 1, 2025, 11:00 Hrs [IST] ...

Daiichi Sankyo announces establishment of upper limits for acquisition of own shares: Tokyo, Japan Saturday, March 1, 2025, 10:00 Hrs [IST] Daiichi Sankyo Company, Limited (hereaf ...

Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...

The Central Drugs Standard Control Organisation (CDSCO) has announced that 145 drug samples tested across the country during the month of February 2025 have been identified as not of standard quality ...

Shardul Nautiyal, Hyderabad Saturday, March 1, 2025, 08:00 Hrs [IST] ...

TN DCA to hold training programme for regulatory inspectorate on regulation of medical devices & filing of complaints: Peethaambaran Kunnathoor, Chennai Saturday, March 1, 2025, 0 ...